NR 565 WEEK 2 LATEST TEST EXAM 2026 STUDY
QUESTIONS WITH CORRECT VERIFIED ANSWERS 100%
GUARANTEED
Why not start with ER/LA opioids? - answers -:-Patients may experience better pain control if
they take opioids when needed rather than on a scheduled basis.
-Taking opioids on a scheduled basis may contribute to tolerance & dose escalations.
medical conditions that may pose serious and life-threatening risks with opioid use - answers -:-
Sleep-disordered breathing such as sleep apnea
-Pregnancy
-Renal or hepatic insufficiency
-Age >= 65
-Certain mental health conditions
-SUD
-Previous nonfatal overdose
Titrating Opioids to >=50 MME/day - answers -:When considering increasing dosage to >=50
MME/day:
-Carefully reassess individual benefits and risks for such a dosage increase, including whether
opioids are meeting the patient's treatment goals
-Increase follow-up intervals to every 1 to 4 weeks
-Consider offering naloxone and overdose prevention education to both patient and the
patient's household members
,Avoid Titrating Opioids to ________ - answers -:>=90 MME/Day
Providers should reevaluate benefits and harms with patients within _______ weeks of starting
opioid therapy or a dose escalation. - answers -:1 to 4 weeks
-provides an opportunity to minimize risks of long-term opioid use by discontinuing opioids
among patients not receiving a clear benefit from these medications.
Providers should reevaluate benefits and harms of continued therapy with patients every
________ or more frequently. - answers -:3 months
Initiating ER/LA Opioids - answers -:-risks for opioid overdose are greatest during the first 3-7
days after opioid initiation or an increase in dosage, particularly when ER/LA opioids are
initiated
• also includes methadone & transdermal fentanyl
-Follow-up within 3 days is appropriate when initiating or increasing the dosage of methadone
-Follow-up within 1 week is appropriate when initiating or increasing the dosage of other ER/LA
opioids
If the patient's dosage is increased to 5/325 mg oxycodone/acetaminophen QID PRN, what
would the daily maximum MME be, assuming the patient takes the full four doses each day?
Select the best answer.
15 MME/day
50 MME/day
30 MME/day
20 MME/day - answers -:30 MME/day
, Rationale:
5 mg oxycodone QID is 20 mg/day. When you multiply 20 by the conversion factor of 1.5, the
result is 30 MME/day.
A follow-up visit within two weeks is appropriate for which of the following reasons? Select all
that apply.
a. Providers should reevaluate benefits and harms with patients within 1 to 4 weeks of starting
opioid therapy or a dose escalation
b. This patient's new dosage is above the 50 MME/day threshold and therefore should be
closely monitored
c. It is less likely that continued opioid therapy will be effective for this patient if she is not
receiving relief 1 month after starting an opioid
d. Reassessment of pain and function within 1 month of initiating opioids provides an
opportunity to minimize risks of long-term opioid use - answers -:a c d
High-Dosing Risks - answers -:add risk without clear benefit. Furthermore, benefits of high-dose
opioids for chronic pain have not been established. A randomized controlled trial found no
difference in pain or function between liberal dose escalation and maintenance of current
opioid dosage
-increase risk of serious harm, including fatal and nonfatal overdose
Dosage and Overdose Risk - answers -:-Dosages >=50 MME/day increase the risk of overdose by
at least two-fold compared with dosages 20 MME/day.
-Dosages greater than 100 MME/day increase overdose risk up to nine times.
Considerations for the Use of ER/LA Opioids - answers -:reserved for severe, continuous pain
-considered only for patients who have received IR opioids daily for at least 1 week without
improvement
QUESTIONS WITH CORRECT VERIFIED ANSWERS 100%
GUARANTEED
Why not start with ER/LA opioids? - answers -:-Patients may experience better pain control if
they take opioids when needed rather than on a scheduled basis.
-Taking opioids on a scheduled basis may contribute to tolerance & dose escalations.
medical conditions that may pose serious and life-threatening risks with opioid use - answers -:-
Sleep-disordered breathing such as sleep apnea
-Pregnancy
-Renal or hepatic insufficiency
-Age >= 65
-Certain mental health conditions
-SUD
-Previous nonfatal overdose
Titrating Opioids to >=50 MME/day - answers -:When considering increasing dosage to >=50
MME/day:
-Carefully reassess individual benefits and risks for such a dosage increase, including whether
opioids are meeting the patient's treatment goals
-Increase follow-up intervals to every 1 to 4 weeks
-Consider offering naloxone and overdose prevention education to both patient and the
patient's household members
,Avoid Titrating Opioids to ________ - answers -:>=90 MME/Day
Providers should reevaluate benefits and harms with patients within _______ weeks of starting
opioid therapy or a dose escalation. - answers -:1 to 4 weeks
-provides an opportunity to minimize risks of long-term opioid use by discontinuing opioids
among patients not receiving a clear benefit from these medications.
Providers should reevaluate benefits and harms of continued therapy with patients every
________ or more frequently. - answers -:3 months
Initiating ER/LA Opioids - answers -:-risks for opioid overdose are greatest during the first 3-7
days after opioid initiation or an increase in dosage, particularly when ER/LA opioids are
initiated
• also includes methadone & transdermal fentanyl
-Follow-up within 3 days is appropriate when initiating or increasing the dosage of methadone
-Follow-up within 1 week is appropriate when initiating or increasing the dosage of other ER/LA
opioids
If the patient's dosage is increased to 5/325 mg oxycodone/acetaminophen QID PRN, what
would the daily maximum MME be, assuming the patient takes the full four doses each day?
Select the best answer.
15 MME/day
50 MME/day
30 MME/day
20 MME/day - answers -:30 MME/day
, Rationale:
5 mg oxycodone QID is 20 mg/day. When you multiply 20 by the conversion factor of 1.5, the
result is 30 MME/day.
A follow-up visit within two weeks is appropriate for which of the following reasons? Select all
that apply.
a. Providers should reevaluate benefits and harms with patients within 1 to 4 weeks of starting
opioid therapy or a dose escalation
b. This patient's new dosage is above the 50 MME/day threshold and therefore should be
closely monitored
c. It is less likely that continued opioid therapy will be effective for this patient if she is not
receiving relief 1 month after starting an opioid
d. Reassessment of pain and function within 1 month of initiating opioids provides an
opportunity to minimize risks of long-term opioid use - answers -:a c d
High-Dosing Risks - answers -:add risk without clear benefit. Furthermore, benefits of high-dose
opioids for chronic pain have not been established. A randomized controlled trial found no
difference in pain or function between liberal dose escalation and maintenance of current
opioid dosage
-increase risk of serious harm, including fatal and nonfatal overdose
Dosage and Overdose Risk - answers -:-Dosages >=50 MME/day increase the risk of overdose by
at least two-fold compared with dosages 20 MME/day.
-Dosages greater than 100 MME/day increase overdose risk up to nine times.
Considerations for the Use of ER/LA Opioids - answers -:reserved for severe, continuous pain
-considered only for patients who have received IR opioids daily for at least 1 week without
improvement
